KaloBios Pharmaceuticals Inc $3.79
|Trade Time:||Dec 11 08:10 PM Eastern Daylight Time|
|Change:||-0.10 (-2.57 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get KBIO Trend Analysis - it has underperformed the S&P 500 by 77%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|1/31/2013||HEALY JAMES||Senior Executive Officer||5,485||$8.00||4,728.45%|
|1/31/2013||5AM Partners LLC||Substantial Shareholder||62,500||$8.00||38.89%|
|1/31/2013||HEALY JAMES||Senior Executive Officer||2,923||$8.00||1,169.20%|
|1/31/2013||HEALY JAMES||Senior Executive Officer||366,592||$8.00||4,815.34%|
KBIO Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!